The American Journal of Endocannabinoid Medicine Officially Launches Under the Haymarket Media US Banner
The launch follows on the heels of Haymarket’s acquisition of AJEM in March 2023; the acquisition expands the medical community’s access to high-quality, trusted, peer-reviewed content on cannabinoid-based therapy. NEW…
Details